Top Markets
Coin of the day
Sun Pharmaceutical Industries Limited Sun Pharmaceutical Industries Limited

Sun Pharmaceutical Industries Limited

SUNPHARMA
Peringkat dalam Saham #477
Sun Pharmaceutical Industries Limited, a generic pharmaceutical company,... Sun Pharmaceutical Industries Limited, a generic pharmaceutical company, develops, manufactures, and markets branded and generic formulations and active pharmaceutical ingredients (APIs) in India and internationally. The company offers formulations in various therapeutic areas, including central nervous system, dermatology, cardiology, oncology and ophthalmic, neuro-psychiatry, gastroenterology, anti-infectives, diabetology, pain/analgesics, vitamins/minerals/nutrients, respiratory, gynaecology, urology, ophthalmology, orthopaedic, nephrology, dental, and other areas. It also provides APIs for anti-cancers, peptides, steroids, sex hormones, and controlled substances; generic medications, such as tablets, capsules, injectables, inhalers, ointments, creams, and liquids; speciality medications, as well as over-the-counter products. The company was founded in 1983 and is based in Mumbai, India.
Harga Saham
$19.63
Kapitalisasi Pasar
$47.10B
Perubahan (1 hari)
1.80%
Perubahan (1 tahun)
-7.33%
Negara
IN
Perdagangan Sun Pharmaceutical Industries Limited (SUNPHARMA)

Kategori

Pendapatan untuk Sun Pharmaceutical Industries Limited (SUNPHARMA)
Pendapatan pada Dec 2025 TTM: $6.31B
Menurut laporan keuangan terbaru dari Sun Pharmaceutical Industries Limited, pendapatan saat ini (TTM) adalah $6.31B. Pada tahun 2024, perusahaan menghasilkan pendapatan sebesar $5.82B peningkatan dibandingkan pendapatan pada tahun 2023 yang sebesar $5.34B. Pendapatan adalah jumlah total yang dihasilkan dari penjualan barang atau jasa. Tidak seperti laba, tidak ada pengeluaran yang dikurangkan.
Riwayat pendapatan Sun Pharmaceutical Industries Limited dari 2004 hingga 2026
Pendapatan pada akhir setiap tahun
Tahun Pendapatan Mengubah
2026 (TTM) $6.31B 2.69%
2025 $6.15B 5.70%
2024 $5.82B 8.91%
2023 $5.34B 4.87%
2022 $5.09B 11.28%
2021 $4.58B 4.98%
2020 $4.36B 4.14%
2019 $4.19B 3.17%
2018 $4.06B -15.97%
2017 $4.83B 13.79%
2016 $4.24B -3.35%
2015 $4.39B 63.63%
2014 $2.68B 29.00%
2013 $2.08B 31.80%
2012 $1.58B 22.91%
2011 $1.28B 47.70%
2010 $869.23M 3.29%
2009 $841.54M 0.33%
2008 $838.79M 70.54%
2007 $491.84M 33.83%
2006 $367.50M 33.92%
2005 $274.42M 20.98%
2004 $226.82M 0.00%
Pendapatan untuk perusahaan serupa atau pesaing
Perusahaan Pendapatan Perbedaan Pendapatan Negara
$4.43B -29.76%
FR
$24.76B 292.14%
DE
$28.60B 352.97%
JP
$9.47B 49.96%
US
$25.92B 310.58%
GB